Lohocla Research Embarks Upon Phase 1 Human Trials
October 31, 2023
- News
Exciting news from Lohocla Research Corporation!
Lohocla, one of our member companies, has just announced the start of Phase 1 clinical trials for Kindolor, a pioneering non-addictive small molecule aimed at treating and preventing chronic pain disorders. This marks a crucial milestone in the journey toward a groundbreaking new treatment.